{"id":"multiple-electrolyte-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperkalemia (if renal function impaired)"},{"rate":null,"effect":"Hypernatremia"},{"rate":null,"effect":"Fluid overload"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is an intravenous fluid replacement therapy that provides a balanced composition of electrolytes and water to restore normal serum electrolyte concentrations and intravascular volume. It is used to correct dehydration, electrolyte imbalances, and maintain homeostasis in patients unable to maintain adequate oral intake or experiencing significant fluid losses.","oneSentence":"Multiple electrolyte solution replaces and maintains essential electrolytes (sodium, potassium, calcium, magnesium, chloride, acetate, phosphate) and fluid balance in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:05.098Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration"},{"name":"Maintenance of electrolyte balance in hospitalized patients"},{"name":"Correction of electrolyte imbalances"}]},"trialDetails":[{"nctId":"NCT07189091","phase":"PHASE4","title":"CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2025-10-07","conditions":"Critical Care, Intensive Care, Fluid Accumulation, Fluid and Electrolyte Imbalance","enrollment":640},{"nctId":"NCT07353853","phase":"NA","title":"Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-01-01","conditions":"IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation","enrollment":1000},{"nctId":"NCT07239713","phase":"NA","title":"Clinical Effects of Ringers Lactate Versus Sterofundin/ Plasmalyte Solution in Patients With Sepsis","status":"RECRUITING","sponsor":"CMH Lahore Medical College and Institute of Dentistry","startDate":"2025-11-15","conditions":"Post Abdominal Surgery, Sepsis Abdominal","enrollment":82},{"nctId":"NCT02014727","phase":"PHASE1","title":"Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2014-01","conditions":"Malaria, Falciparum","enrollment":66},{"nctId":"NCT05752279","phase":"PHASE3","title":"Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-03-14","conditions":"Diabetic Ketoacidosis","enrollment":680},{"nctId":"NCT06812065","phase":"NA","title":"Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts","status":"RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2022-12-07","conditions":"Warts","enrollment":300},{"nctId":"NCT03829488","phase":"PHASE3","title":"Better Evidence for Selecting Transplant Fluids","status":"COMPLETED","sponsor":"The University of Queensland","startDate":"2018-01-26","conditions":"End Stage Kidney Disease, Delayed Graft Function, Kidney Transplant; Complications","enrollment":808},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT06374823","phase":"PHASE4","title":"Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-05","conditions":"Critical Care, Hyperchloremia, Hemorrhagic Stroke","enrollment":342},{"nctId":"NCT03446612","phase":"PHASE2","title":"Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2019-01-10","conditions":"Anaemia","enrollment":6},{"nctId":"NCT03278548","phase":"PHASE4","title":"Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2017-09-28","conditions":"Hypovolaemia Due to Acute Blood Loss","enrollment":2289},{"nctId":"NCT04409873","phase":"PHASE2","title":"Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2021-03-31","conditions":"COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":54},{"nctId":"NCT06076590","phase":"PHASE4","title":"Impact of Multiple Electrolytes Injection Ⅱ and Saline on Hyperchloremia in Patients With Aneurysmal Subarachnoid Hemorrhage:a Pilot Study","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-11-01","conditions":"Aneurysmal Subarachnoid Hemorrhage, Hyperchloremia","enrollment":60},{"nctId":"NCT05876195","phase":"NA","title":"KLH Challenge to Explore the Human Immune Response","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2023-03-01","conditions":"Immune Response","enrollment":39},{"nctId":"NCT05156632","phase":"PHASE3","title":"Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above","status":"WITHDRAWN","sponsor":"Sinovac Research and Development Co., Ltd.","startDate":"2023-02-20","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04133987","phase":"PHASE2","title":"Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2018-10-15","conditions":"Dengue","enrollment":252},{"nctId":"NCT03338218","phase":"PHASE4","title":"Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2019-02-23","conditions":"Hypovolemia Due to Acute Blood Loss","enrollment":238},{"nctId":"NCT02835157","phase":"NA","title":"Balanced Crystalloid vs. Saline in Children With Septic Shock","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2017-04-01","conditions":"Septic Shock, Shock","enrollment":708},{"nctId":"NCT03345992","phase":"PHASE3","title":"Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2017-12-15","conditions":"Sepsis, Pneumonia, Gram-Negative Bacteria Infection","enrollment":110},{"nctId":"NCT03106922","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children","status":"UNKNOWN","sponsor":"Alfasigma S.p.A.","startDate":"2016-04","conditions":"Bowel Preparation Before Colonoscopy","enrollment":430},{"nctId":"NCT01234883","phase":"PHASE4","title":"Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis","status":"TERMINATED","sponsor":"Baxter Healthcare Corporation","startDate":"2011-06","conditions":"Dehydration, Gastroenteritis","enrollment":100},{"nctId":"NCT01117649","phase":"PHASE4","title":"Plasma Volume Replacement (PVR) Therapy With Colloid and Crystalloid Solutions","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2010-05","conditions":"Plasma Volume Replacement, Surgery of the Pancreatic Head","enrollment":63},{"nctId":"NCT01470521","phase":"PHASE2","title":"Worms for Immune Regulation of Multiple Sclerosis","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2011-12","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":72},{"nctId":"NCT01689506","phase":"PHASE4","title":"Fluid Resuscitation in Patients Suffering From Burns Injury","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2012-12","conditions":"Burns","enrollment":11},{"nctId":"NCT01725256","phase":"PHASE2","title":"A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)","status":"TERMINATED","sponsor":"Aires Pharmaceuticals, Inc.","startDate":"2012-11","conditions":"Pulmonary Arterial Hypertension","enrollment":29},{"nctId":"NCT01973504","phase":"PHASE2","title":"Phase 2c Dose Comparison Study of MP4OX in Trauma","status":"WITHDRAWN","sponsor":"Sangart","startDate":"2013-12","conditions":"Trauma, Hemorrhagic Shock, Lactic Acidosis","enrollment":""},{"nctId":"NCT01925001","phase":"PHASE2","title":"Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis","status":"WITHDRAWN","sponsor":"Sangart","startDate":"2013-10","conditions":"Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease","enrollment":""},{"nctId":"NCT01262196","phase":"PHASE2","title":"Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients","status":"COMPLETED","sponsor":"Sangart","startDate":"2011-05","conditions":"Shock, Hemorrhagic, Shock, Traumatic, Acidosis, Lactic","enrollment":348},{"nctId":"NCT01356485","phase":"PHASE1","title":"Safety Study of MP4CO in Adult Sickle Cell Patients","status":"COMPLETED","sponsor":"Sangart","startDate":"2012-01","conditions":"Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disease","enrollment":32},{"nctId":"NCT01004198","phase":"PHASE2","title":"Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients","status":"COMPLETED","sponsor":"Sangart","startDate":"2009-12","conditions":"Shock, Hemorrhagic, Shock, Traumatic, Acidosis, Lactic","enrollment":51},{"nctId":"NCT01073930","phase":"PHASE3","title":"Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-05","conditions":"Bowel Preparation","enrollment":608},{"nctId":"NCT01356407","phase":"PHASE3","title":"Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-01","conditions":"Colonoscopy","enrollment":300},{"nctId":"NCT01073943","phase":"PHASE3","title":"Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-05","conditions":"Bowel Preparation","enrollment":603},{"nctId":"NCT01304394","phase":"PHASE3","title":"Safety During Use of Paediatric Triple Chamber Bag Formulas","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2008-02","conditions":"Infant Nutrition Disorders, Infant, Premature, Diseases, Digestive System Disorders","enrollment":161},{"nctId":"NCT00857272","phase":"PHASE4","title":"F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects","status":"COMPLETED","sponsor":"Braintree Laboratories","startDate":"2009-02","conditions":"Colonoscopy","enrollment":308},{"nctId":"NCT00301483","phase":"PHASE2","title":"A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects","status":"UNKNOWN","sponsor":"Biopure Corporation","startDate":"2004-07","conditions":"Wounds and Injuries","enrollment":53}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Plasma Lyte A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)","Multiple Electrolytes injection II"],"phase":"marketed","status":"active","brandName":"multiple electrolyte solution","genericName":"multiple electrolyte solution","companyName":"Baxter Healthcare Corporation","companyId":"baxter-healthcare-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Multiple electrolyte solution replaces and maintains essential electrolytes (sodium, potassium, calcium, magnesium, chloride, acetate, phosphate) and fluid balance in the body. Used for Fluid and electrolyte replacement in dehydration, Maintenance of electrolyte balance in hospitalized patients, Correction of electrolyte imbalances.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}